CHTR
Charter Communications, Inc.
CHTR's fundamentals are weak: its operating margin fell 13 points to 11% and earnings per share fell 73%, though it turned 7.1% of its revenue into free cash flow. At 14x earnings, it's trading above its usual 12x. Its downside scenario is about eight times its upside.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
CHTR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
CHTR's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
CHTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.1x | $133 | — |
| Cheap | 7.3x | $69.62 | -48% |
| Fair | 12x | $118 | -11% |
| Current | 14x | $133 | — |
| Expensive | 42x | $404 | +205% |
Historical ranges are pointers, not guarantees.
CHTR has the edge over NBIS in the historical PE scenario, which offers more potential upside but is not a forecast.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
CHTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CHTR, but weaker profitability. However, they disagree widely on these estimates.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
CHTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $42.65 | +344% |
| Q3 2026 | $9.60 | -73% |
| Q2 2026 | $38.44 | +5.2% |
| Q1 2026 | $36.96 | +3.1% |
| Q4 2025 | $36.21 | +3.5% |
| Q3 2025 | $36.05 | +13% |
| Q2 2025 | $36.53 | +17% |
| Q1 2025 | $35.84 | +16% |
| Q4 2024 | $34.97 | +17% |
CHTR earned $9.60 per share over the past year, down 73% from the year before.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has the edge over CHTR in the latest year-over-year earnings comparison.
CHTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.9B | +9.1% |
| Q2 2026 | $13.5B | -1.7% |
| Q1 2026 | $13.6B | -1% |
| Q4 2025 | $13.6B | -2.3% |
| Q3 2025 | $13.7B | -0.9% |
| Q2 2025 | $13.8B | +0.6% |
| Q1 2025 | $13.7B | +0.4% |
| Q4 2024 | $13.9B | +1.6% |
CHTR has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -24% | -47 points |
| Q2 2026 | 23% | -1.2 points |
| Q1 2026 | 24% | 0 points |
| Q4 2025 | 24% | -0.4 points |
| Q3 2025 | 23% | -1.3 points |
| Q2 2025 | 24% | 0 points |
| Q1 2025 | 24% | +0.7 points |
| Q4 2024 | 24% | +0.5 points |
CHTR's operating margin was −24% last quarter, down 47 points from the same quarter a year ago, near the bottom of its range since 2019.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
CHTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1B | -30% |
| Q2 2026 | $1.1B | +45% |
| Q1 2026 | $1.4B | -21% |
| Q4 2025 | $426M | +7% |
| Q3 2025 | $1.4B | +6.5% |
| Q2 2025 | $726M | -27% |
| Q1 2025 | $1.8B | +336% |
| Q4 2024 | $398M | -60% |
CHTR's free cash flow has been positive every quarter for seven years: $3.9B over the past year, down 11% from the year before.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
CHTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.6% | -4.3M shares |
| 1 year | -14% | -19.5M shares |
| 3 years | -23% | -35.1M shares |
| 5 years | -38% | -70.2M shares |
| Available history | -46% | -101M shares |
CHTR has 117M diluted shares, down 14% from a year ago, with $2.7B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $21M |
| Q2 2026 | $852M |
| Q1 2026 | $1B |
| Q4 2025 | $766M |
| Q3 2025 | $2.1B |
| Q2 2025 | $1.5B |
| Q1 2025 | $802M |
| Q4 2024 | $114M |
CHTR spent $2.7B buying back its own shares over the past year, down 41% from the year before.
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over CHTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
CHTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.0x | High |
| Q2 2026 | 4.4x | High |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 4.4x | High |
| Q3 2025 | 4.4x | High |
| Q2 2025 | 4.3x | High |
| Q1 2025 | 4.3x | High |
| Q4 2024 | 4.3x | High |
CHTR's net debt is about 7.0 years of its operating earnings (EBITDA), up from 4.4 years a year ago.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
CHTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.5 | Neutral |
| Stochastic | 32.9 | Neutral |
CHTR's weekly RSI is 47 (neutral) and its Stochastic is 33 (neutral).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CHTR PE vs Communication Services Sector
| Metric | CHTR | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 16x | 16% below |
| PE % | 57 | 26 | 31 pts above |
CHTR has the edge over NBIS on valuation relative to its sector.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
CHTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $113.3 | 17% above |
| 20 week MA | $130.5 | 1.6% above |
| 50 week MA | $168.2 | 21% below |
| 100 week MA | $247.3 | 46% below |
| 200 week MA | $300.4 | 56% below |
CHTR has stronger trend alignment. CHTR is above 2 of 5 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
CHTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $483.7 | $656.5 | +36% |
| 2021 | $656.5 | $648.3 | -1.2% |
| 2022 | $648.3 | $333.9 | -48% |
| 2023 | $333.9 | $388.7 | +16% |
| 2024 | $388.7 | $348.7 | -10% |
| 2025 | $348.7 | $207.2 | -41% |
| 2026 YTD | $207.2 | $132.7 | -36% |
CHTR has finished lower in four of the last six years. It's down 36% so far in 2026.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over CHTR on returns for 2026, with the stronger performance.